Skip to main content
. 2015 Aug 21;8:2209–2214. doi: 10.2147/OTT.S89606

Figure 2.

Figure 2

Time to second tumor progression in the two groups.

Note: Patients received IP until progression and then EP (group A), or the reverse treatment sequence (group B).

Abbreviations: IP, irinotecan/cisplatin; EP, etoposide/cisplatin.